Tag: #Global Trends

GSK announced that Risvanzutibart (Ris-Rez), an antibody-drug conjugate (ADC) targeting B7-H3, achieved positive results in a Phase III clinical trial... Read more

Key Development The European Commission has approved AbbVie and Genmab's bispecific antibody TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab... Read more

Key Development AstraZeneca and Ionis Pharmaceuticals announced that a late-stage clinical trial evaluating eplontersen for transthyretin amyloid cardiomyopathy (ATTR-CM) failed... Read more

Key Development China has taken another significant step in reshaping diabetes care by adding semaglutide, the second GLP-1 receptor agonist... Read more

Key Development The decision to end a long-standing research collaboration between GSK and Alector marks more than the conclusion of... Read more

Key Development Novo Nordisk has launched Awiqli (insulin icodec) in India, making the country one of the earliest markets to... Read more

Key Development AstraZeneca and Daiichi Sankyo are reportedly close to reaching a pricing agreement with the United Kingdom's National Institute... Read more

Key Development The Democratic Republic of Congo (DRC) has confirmed a suspected Ebola case in Tshopo Province, extending the country's... Read more

Key Development The global obesity drug market is entering a new phase as Kailera Therapeutics’ oral GLP-1 candidate HRS-7535 (KAI-7535)... Read more